Jazz Pharmaceuticals to Report 2021 Second Quarter Financial Results on August 3, 2021PRNewsWire • 07/20/21
Best Medical Marijuana Stock To Buy In 2021? 2 With Long Term Potential Right NowMarijuanaStocks • 07/14/21
Jazz Pharmaceuticals Announces Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) Investor Webcast on July 20, 2021PRNewsWire • 07/13/21
3 Value Stocks That'll Make You Richer in the Second Half of 2021 (and Beyond)The Motley Fool • 07/06/21
Jazz Pharmaceuticals Announces U.S. FDA Approval of Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaPRNewsWire • 07/01/21
Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral SolutionPRNewsWire • 06/25/21
Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired GW Pharmaceuticals plcPRNewsWire • 06/17/21
Jazz Pharmaceuticals and Leading Cancer Organizations Collaborate to Launch First and Only Digital Hub Focused Exclusively on Emotional, Social and Physical Health Needs of Small Cell Lung Cancer CommunityPRNewsWire • 06/14/21
Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of GW Pharmaceuticals, PLC In The Southern District Of CaliforniaPRNewsWire • 06/04/21